Clearside Biomedical Inc (CLSD) — Cash Flow-to-Debt Ratio
Clearside Biomedical Inc (CLSD) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of $-5.48 Million could theoretically repay 0% of its total liabilities ($65.59 Million) in one year. See financial flexibility index of Clearside Biomedical Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearside Biomedical Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Clearside Biomedical Inc across 13 annual periods. For the full cash flow conversion analysis, see Clearside Biomedical Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Clearside Biomedical Inc (2012–2024)
Year-by-year debt coverage analysis for Clearside Biomedical Inc. Check CLSD cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.39x | $-24.70 Million | $63.98 Million | ▼ -6.3% |
| 2023 | -0.36x | $-18.14 Million | $49.93 Million | ▼ -10.6% |
| 2022 | -0.33x | $-13.37 Million | $40.70 Million | ▲ +84.9% |
| 2021 | -2.18x | $-10.73 Million | $4.93 Million | ▼ -75.3% |
| 2020 | -1.24x | $-13.12 Million | $10.56 Million | ▲ +28.3% |
| 2019 | -1.73x | $-27.07 Million | $15.62 Million | ▲ +55.1% |
| 2018 | -3.86x | $-79.20 Million | $20.50 Million | ▼ -44.3% |
| 2017 | -2.68x | $-51.08 Million | $19.08 Million | ▼ -55.1% |
| 2016 | -1.73x | $-22.71 Million | $13.15 Million | ▼ -616.7% |
| 2015 | -0.24x | $-13.90 Million | $57.71 Million | ▲ +22.1% |
| 2014 | -0.31x | $-9.12 Million | $29.51 Million | ▲ +41.8% |
| 2013 | -0.53x | $-6.84 Million | $12.88 Million | ▲ +88.1% |
| 2012 | -4.48x | $-3.18 Million | $709.00K | — |